- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 979.95M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 979.95M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 979.95M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $8.84M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $7.02M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.41M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.33M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.55M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.7M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $73.22M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $81.77M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $142.99M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $207.36M |
| Capex | Q1 2025 · Mar 31, 2024 | $2.34M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.59M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $231.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $240.02M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.77M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.16M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.39M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $4.12M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.15M |
| Revenue | Q1 2025 · Mar 31, 2024 | $6.26M |